2024-12-01 00:26:59
AKESO'S NGF MONOCLONAL ANTIBODY (AK115) APPROVED TO INITIATE CLINICAL TRIAL IN PAIN (INCLUDING CANCER PAIN)
Corporate/ 2023-07-24
AKESO'S NGF MONOCLONAL ANTIBODY (AK...

HONG KONG,Feb. 10,2022-- Akeso,Inc. (9926.HK) announced that the clinical trial application of the innovative nerve growth factor (NGF) mono...

Ucello Therapeutics Completes US$25 Million Series A Financing
Health/ 2023-07-22
Ucello Therapeutics Completes US$25 Mill...

SAN DIEGO,Calif. and CHENGDU,China,Feb. 11,2022-- Ucello Therapeutics ("Ucello"),a biotechnology company developing universal CAR-...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release